Profit

Sun Pharma To Release Salary To Ex-Ranbaxy Representatives Using Company App

 Share
EMAIL
PRINT
COMMENTS
Sun Pharma To Release Salary To Ex-Ranbaxy Representatives Using Company App

Sun Pharma had asked the erstwhile Ranbaxy representatives to switch over to an app provided by it.


New Delhi: Backed by a Bombay High Court order, drug major Sun Pharmaceutical Industries on Wednesday said it will release salaries of the erstwhile Ranbaxy medical representatives only if they used a company provided software application to report daily activity reports.

A section of ex-Ranbaxy medical representatives (MRs) had challenged in the industrial court in Mumbai the move by Sun Pharma to do away with a software application used by erstwhile Ranbaxy MRs for reporting daily activity reports (DAR) and asked them to switch over to a system provided by it.

The industrial court had granted an interim order in favour of the medical representatives. It was challenged by the company in the Bombay High Court.

The court "has granted the company's request for using the Target Application as the platform for DAR and passed an order in which it has directed the said MRs to start reporting on the Target Application retrospectively", Sun Pharma said in a filing to the BSE.

"We have stated very clearly in the court that the company will release the salaries provided these medical representatives submit their daily activity reports (DAR) using Target Application," it added.

As on today the migration of all medical representatives of the erstwhile Ranbaxy to Target Application has been completed and around 94 per cent of them are reporting on it. The balance 6 per cent are refusing to submit their DAR on Target Application, Sun Pharma said.

As part of the integration of erstwhile Ranbaxy in Sun Pharma, it was decided to use Target Application as a single platform for DAR for the India field force, it added.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Top